Home

Alector, Inc. - Common Stock (ALEC)

1.8400
0.00 (0.00%)

Alector Inc is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases by harnessing the immune system

The company aims to discover and bring to market treatments that address the underlying mechanisms of conditions such as Alzheimer's disease. Through advanced research and a proprietary platform, Alector is dedicated to unlocking new pathways in neuroscience and providing hope for patients dealing with these challenging diseases. Their strategic approach combines drug development with a strong emphasis on understanding the interactions between the immune system and the nervous system.

SummaryNewsPress ReleasesChartHistoricalFAQ
Neurology-Focused Alector Downgraded On Failed Alzheimer's Study, BofA Securities Highlights Lack Of Catalystsbenzinga.com
Alector's AL002 misses primary endpoint in Alzheimer's trial. BofA downgrades stock, cuts price target, and highlights near-term challenges.
Via Benzinga · December 4, 2024
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 30talkmarkets.com
Via Talk Markets · November 30, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 26, 2024
Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Viewsbenzinga.com
Via Benzinga · November 26, 2024
Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Resultsbenzinga.com
Via Benzinga · November 26, 2024
Recap: Alector Q4 Earningsbenzinga.com
Via Benzinga · February 27, 2024
Earnings Scheduled For February 27, 2024benzinga.com
Companies Reporting Before The Bell • Gaotu Techedu (NYSEGOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via Benzinga · February 27, 2024
Earnings Outlook For Alectorbenzinga.com
Via Benzinga · February 26, 2024
Why Alector (ALEC) Stock Is Diving Todaybenzinga.com
Alector shares are trading lower by 14.9% during Wednesday's session. The company announced the pricing of a $75 million public offering.
Via Benzinga · January 17, 2024
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforcebenzinga.com
Alector's AL002 fails in Phase 2 Alzheimer's trial, halting extension study; focus shifts to other programs as workforce is cut by 17%.
Via Benzinga · November 26, 2024
US Stocks Mixed; Best Buy Posts Downbeat Earningsbenzinga.com
Via Benzinga · November 26, 2024
Leslie's Posts Weak Results, Joins Zoom Video And Other Big Stocks Moving Lower In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 26, 2024
Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · November 26, 2024
Perion Network Cuts Revenue Outlook, Joins Skye Bioscience And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 10, 2024
ALEC Stock Earnings: Alector Beats EPS, Beats Revenue for Q1 2024investorplace.com
ALEC stock results show that Alector beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setbackinvestors.com
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via Investor's Business Daily · March 28, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesdayinvestorplace.com
We're starting Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!
Via InvestorPlace · March 6, 2024
Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughsinvestorplace.com
These three companies are developing treatments for brain diseases that have a great deal of potential, making them top neuroscience stocks. 
Via InvestorPlace · January 23, 2024
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Shares of Airspan Networks Holdings Inc. (NASDAQMIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.
Via Benzinga · January 17, 2024
SolarEdge Technologies, Calavo Growers, Fisker And Other Big Stocks Moving Lower On Wednesdaybenzinga.com
U.S. stocks traded lower, with the Nasdaq Composite falling more than 150 points on Wednesday.
Via Benzinga · January 17, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · January 16, 2024
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024investors.com
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via Investor's Business Daily · January 5, 2024
Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Fridaybenzinga.com
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Friday. Here are some other big stocks recording gains in today’s session.
Via Benzinga · December 15, 2023
Alector Upgraded, Analyst Sees High Reward Potential Ahead of Alzheimer's Disease Candidate's Phase 2 Resultsbenzinga.com
Stifel has upgraded Alector Inc (NASDAQALEC), noting that while Alzheimer's is a very high risk, the probability of success for AL002 (TREM2 agonist) is above average, and the stock risk/reward is highly attractive ahead of phase 2 data in expected in Q4 2024.
Via Benzinga · December 14, 2023
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Shares of Amtech Systems, Inc. (NASDAQASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.
Via Benzinga · December 14, 2023